by Ashley Davis | Jul 23, 2019 | Publications and Articles
Classical analyses of pharmaceutical pipelines from 1990 to 2010 reported increasing attrition rates and duration of clinical trials, leading to a perception of a “productivity crisis” in this sector. However, in contrast, a more recent analysis of over 45,000... by Ashley Davis | Jun 27, 2019 | Publications and Articles
Computer-based virtual reality assessments of functional capacity have shown promise as a reliable and valid way to assess individuals with multi-episode schizophrenia. However, there has been little research utilizing this innovative approach with young patients who... by Ashley Davis | Jun 25, 2019 | Case Study
How VeraSci supported authentic translation and cultural adaptation of neurocognitive assessments in a multinational, large scale, long-term clinical trial for delaying the onset of Mild Cognitive Impairment stage of Alzheimer’s Disease. by Ashley Davis | Jun 20, 2019 | Publications and Articles
The Schizophrenia Cognition Rating Scale (SCoRS) is a 20-item interview-based clinical assessment that evaluates cognitive deficits and the degree to which these deficits impair patients’ day-to-day functioning. It was originally developed in 2001 at Duke University... by Ashley Davis | Jun 5, 2019 | Case Study
How VeraSci effectively and efficiently provided support to a large scale, multinational, long-term clinical trial for pre-clinical phase Alzheimer’s Disease.